1 Poor adherence to antipsychotic medication in people with schizophrenia: diffusion, consequences, and contributing factors
Premise
Role of antipsychotics in the treatment of schizophrenia
Compliance versus adherence
Assessment of medication adherence
Frequency of poor adherence to antipsychotics
Consequences of poor adherence to antipsychotics
Determinants and moderators of adherence to antipsychotics
Present and medium-term perspectives
Closing Remarks
2 Pharmacological strategies to enhance adherence in schizophrenia
Introduction
Pharmacological factors contributing to non-adherence: efficacy, side effects, regimen, co-therapies
First vs Second generation antipsychotics: efficacy, tolerability and the adherence issue
Long-acting injectable antipsychotics
Conclusion. 3 Non-pharmacological strategies to enhance adherence and continuity of care in schizophrenia
Introduction
Factors Influencing (non-)adherence in Schizophrenia
Interventions to Enhance Adherence. Research and Clinical Evidence
Comprehensive Review of Psychosocial and Programmatic Interventions to Enhance Adherence to Antipsychotic Medication in Schizophrenia
Summary of Main Results and Evidences
Conclusions and Future Directions
4 Psychological issues in improving adherence and alliance
The patient-doctor relationship as a determinant of adherence to treatment
Alliance and psychodynamic issues
Towards the concept of concordance of the therapeutic project.